Aimwell deploys autonomous adversarial agents that pressure-test AI-generated research before it reaches the boardroom, the FDA, or your balance sheet.
Black-box outputs reach leadership unchallenged. One flawed assumption can redirect a $200M trial.
Regulatory teams inherit AI-generated submissions they didn't validate. The FDA doesn't accept "the model said so."
Investment committees approve capital deployment based on AI confidence scores they cannot audit.
"Speed without verification is liability."
Aimwell does not compete with AI research platforms. We validate their outputs. We are the system that sits above them — and decides whether their results can be trusted.
Simulates FDA reviewer logic against your research brief. Surfaces deficiencies in study design, endpoint definitions, and statistical methodology before submission.
Maps rival pipeline positions, predicts competitive responses, and identifies freedom-to-operate risks your team hasn't modeled.
Cross-references your trial design against 40,000+ historical failure patterns. Identifies hidden risks in enrollment criteria, dosing assumptions, and interim analysis design.
Models investor exposure across scenario trees. Quantifies capital at risk if agent-identified failure modes materialize.
Every AI research platform produces outputs. Aimwell's Shadow Lab receives those outputs, runs its own independent validation stack, and returns a verdict — before anyone acts on the original result.
"We verify what your AI scientists produce — before you bet the company on it."
Most platforms reset with every query. Aimwell compounds with every decision your organization makes — turning your history into your most defensible competitive asset.
Every agent interaction, every verdict, every outcome — logged, indexed, queryable. Your past is never lost. It is working for you.
Failure patterns accumulate into predictive intelligence. Your 50th trial benefits from your first 49. The system gets sharper with every decision you make.
Your institutional memory cannot be replicated by a competitor starting fresh. It compounds with every decision. It is yours alone.
No ambiguous summaries. No caveated paragraphs. Every research output receives a verdict — with the multi-agent consensus and confidence score required to defend it in the room.
Aimwell serves the decision-makers who carry institutional liability when AI research fails — and who have no current mechanism to verify it before it does.
You sign off on submissions. We make sure what you sign has already survived adversarial review — by an agent simulating the exact reviewer logic you will face.
Before you license an asset, we tell you what the seller's AI missed — what failure modes were never modeled, and what the data room didn't surface.
Before you deploy capital, we model the downside scenarios the pitch deck didn't show you — quantified, probability-weighted, and audit-ready.
Request a Shadow Lab demonstration. We'll run your last three research outputs through our adversarial stack and show you what we find.
Request Adversarial Audit →